WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
-$393M
(-3.6%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
$123M |
| 2 |
Electronic Arts
EA
|
$102M |
| 3 |
Chord Energy
CHRD
|
$100M |
| 4 |
Quest Diagnostics
DGX
|
$89.2M |
| 5 |
Sensata Technologies
ST
|
$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
$138M |
| 2 |
Avnet
AVT
|
$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$73.5M |
| 5 |
Amazon
AMZN
|
$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Rocket Pharmaceuticals
RCKT
$354M
| $12.1M | 0.12% |
+561,966
| New | +$12.1M |
|
227
Disc Medicine
IRON
$2.11B
| $12.1M | 0.12% |
+267,863
| New | +$12.1M |
|
|
BCYC
228
Bicycle Therapeutics
BCYC
$496M
| $11.9M | 0.11% |
+586,622
| New | +$11.9M |
|
229
Core & Main
CNM
$12.7B
| $11.5M | 0.11% |
235,159
-230,641
| -50% | -$11.3M |
|
230
Dynavax Technologies
DVAX
$1.18B
| $11.3M | 0.11% |
1,006,027
-362,740
| -27% | -$4.07M |
|
231
Corbus Pharmaceuticals
CRBP
$121M
| $11.3M | 0.11% |
249,259
+208,278
| +508% | +$9.42M |
|
232
Arvinas
ARVN
$575M
| $11.3M | 0.11% |
423,124
+920
| +0.2% | +$24.5K |
|
233
Esperion Therapeutics
ESPR
$540M
| $11.2M | 0.11% |
5,049,808
-2,872,421
| -36% | -$6.38M |
|
|
NWLI
234
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $11.2M | 0.11% |
22,510
-24,291
| -52% | -$12.1M |
|
235
Immunome
IMNM
$916M
| $11.2M | 0.11% |
922,892
-395,164
| -30% | -$4.78M |
|
236
Ultragenyx Pharmaceutical
RARE
$3.07B
| $11M | 0.1% |
266,790
-133,334
| -33% | -$5.48M |
|
237
Waste Connections
WCN
$46.1B
| $11M | 0.1% |
62,523
-48,862
| -44% | -$8.57M |
|
238
American Financial Group
AFG
$11.6B
| $10.9M | 0.1% |
88,846
+28,040
| +46% | +$3.45M |
|
239
Cytokinetics
CYTK
$6.34B
| $10.7M | 0.1% |
+198,181
| New | +$10.7M |
|
240
Travere Therapeutics
TVTX
$1.93B
| $10.5M | 0.1% |
+1,276,878
| New | +$10.5M |
|
241
Insmed
INSM
$30.7B
| $10.4M | 0.1% |
+155,155
| New | +$10.4M |
|
242
JB Hunt Transport Services
JBHT
$13.9B
| $10.4M | 0.1% |
+64,885
| New | +$10.4M |
|
243
Duolingo
DUOL
$12.4B
| $10.2M | 0.1% |
+48,743
| New | +$10.2M |
|
244
Allogene Therapeutics
ALLO
$255M
| $10.2M | 0.1% |
4,358,989
+1,725,013
| +65% | +$4.02M |
|
245
MoonLake Immunotherapeutics
MLTX
$3.77B
| $9.97M | 0.1% |
226,717
+19,302
| +9% | +$849K |
|
246
Texas Roadhouse
TXRH
$11.2B
| $9.86M | 0.09% |
57,421
-109,391
| -66% | -$18.8M |
|
247
Erasca
ERAS
$457M
| $9.76M | 0.09% |
4,134,036
+3,243,243
| +364% | +$7.65M |
|
248
Day One Biopharmaceuticals
DAWN
$773M
| $9.75M | 0.09% |
707,531
+434,993
| +160% | +$5.99M |
|
|
JNPR
249
DELISTED
Juniper Networks
JNPR
| $9.65M | 0.09% |
+264,802
| New | +$9.65M |
|
250
DexCom
DXCM
$31.6B
| $9.5M | 0.09% |
83,798
-138,996
| -62% | -$15.8M |
|